Yatharth Hospital Share Price Target 2024, 2025, 2027, 2030, 2040

Introduction

In this blog, we delve into the Yatharth Hospital Share Price Target for the years 2024, 2025, 2027, 2030, and 2040. We have conducted thorough research and consulted experts to present a comprehensive analysis of the company’s growth, performance, and future prospects.

What is Yatharth Hospital?

Yatharth Hospital and Trauma Care Centre, established in February 2008, is a leading healthcare provider in Noida. The hospital network includes three super-specialty hospitals in Noida, Greater Noida, and Greater Noida West, with a total capacity of 1200 beds. A new branch in Jhansi Orchha is also part of the network.

Overview of Yatharth Hospital

Ranked among the top 10 private hospitals in Delhi, Yatharth Hospital is accredited by the National Accreditation Board for Hospitals and Healthcare Providers (NABH). The hospital offers a wide range of medical services, including Orthopedics, Nephrology, Urology, Neurosciences, Gastroenterology, Obstetrics and Gynecology, Cardiology, and more. Equipped with modern facilities and a team of experienced medical professionals, Yatharth Hospital provides high-quality healthcare services.

Economic Details of Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospital is publicly traded and shows strong financial growth. Here are some key economic details:

Annual Performance of Yatharth Hospital

To make informed investment decisions, it’s essential to understand the company’s performance metrics:

PE Ratio (Price To Earnings Ratio): The PE ratio of Yatharth Hospital is 48.89, indicating the price investors are willing to pay for each rupee of earnings.

Return on Equity (ROE): With an ROE of 44.45%, Yatharth Hospital demonstrates effective utilization of equity capital to generate profits.

Operating Cash Flow Ratio: The company has an operating cash flow ratio of ₹25.59 crore, reflecting its ability to generate cash from core operations.

Yatharth Hospital Share Price Target 2024 to 2040

The share price targets for Yatharth Hospital are based on expert analysis and projections. Here are the targets for various years:

Detailed Analysis of Share Price Targets

Yatharth Hospital Share Price Target 2024

By the end of 2023, Yatharth Hospital achieved a revenue of ₹500 crore, with significant contributions from its branches in Greater Noida and Noida. Despite competition in the private hospital sector, Yatharth Hospital remains a top player due to its excellent facilities and services. The share price target for 2024 is projected to be ₹450 to ₹475.

Yatharth Hospital Share Price Target 2025

The company’s profit growth has been impressive, with a notable increase from ₹42.15 crore in 2022 to ₹63.12 crore in 2023. The sales growth has also surged by 40% over the past three years. For 2025, the share price is expected to reach ₹495 to ₹550.

Yatharth Hospital Share Price Target 2026

As the company continues to grow, the share price target for 2026 is forecasted to be ₹580 to ₹620.

Yatharth Hospital Share Price Target 2027

With substantial investments in modern medical equipment and infrastructure, Yatharth Hospital’s assets have increased significantly. The share price target for 2027 is projected to be ₹630 to ₹690.

Yatharth Hospital Share Price Target 2030

Yatharth Hospital’s ongoing development and sales growth are expected to continue, driven by government support and a growing healthcare market. The share price target for 2030 is ₹910 to ₹960.

Yatharth Hospital Share Price Target 2040

By 2040, Yatharth Hospital is anticipated to complete several new projects, further boosting its market position and share price. The long-term share price target for 2040 is ₹1820 to ₹1900.

Investor Types and Ratios of Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospital’s investor base is diverse, comprising promoters, public investors, foreign institutional investors (FIIs), and domestic institutional investors (DIIs).

Advantages and Disadvantages of Yatharth Hospital Share

Advantages

• Profit Growth: The company’s net profit has increased significantly in the past two years, enhancing its financial stability.
• Strong Management: Effective management policies contribute to a high ROE of 45.12%.
• Revenue Growth: The company has experienced a 38.25% revenue growth over the past three years.
• Promoter Holding: A high promoter holding capacity of 65.23% attracts substantial investor interest.

Disadvantages

• Promoter Pledging: The company’s promoter pledging capacity is not favorable, potentially affecting growth.
• Competition: The hospital sector is highly competitive, requiring Yatharth Hospital to continuously innovate and improve.

Also Read: Varun Beverages Share Price Target 2024, 2025, 2027 to 2040

Frequently Asked Questions (FAQ)

Conclusion

Yatharth Hospital, with its robust performance and strategic growth initiatives, presents a promising investment opportunity. The projected share price targets indicate significant potential for growth. As always, potential investors are advised to conduct thorough research and consult with certified financial advisors before making investment decisions.

Disclaimer: This blog is for educational purposes only and should not be considered as financial advice. Always consult with a SEBI-registered advisor before making any investment decisions.